By Ben Harbour, expert-trainer of Omnichannel Launch Excellence for Medical & Marketing
Pharma launches are often won or lost long before approval. Yet most organizations over-focus on the final 12 months. Evidence shows only 47% of companies start digital engagement early, despite clear advantages for those that do.
HCPs expect evidence before promotion. Early KOL engagement and data-driven education secure credibility long before launch.
Disease education, biomarker testing, and infrastructure readiness cannot be rushed. Starting 24–48 months ahead allows enough lead-in.
The first mover sets the narrative. If competitors shape the discussion early, you risk playing catch-up at launch.
Collect insights, build the evidence base, establish disease awareness campaigns, and engage advocacy groups.
Segment and prioritize customers, co-create educational content, test digital channels, and refine value messaging.
Execute integrated omnichannel campaigns across personal and non-personal channels, using predictive KPIs to monitor readiness.
👉 Launch excellence doesn’t start at launch. It starts years earlier, with Medical and Marketing working hand-in-hand to build awareness, trust, and adoption through early omnichannel engagement.